New Delhi, Dec 14 (PTI) The Covid pandemic brought out the importance of investing in affordable technologies, innovation to deliver important life-saving vaccines, said Kiran Mazumdar-Shaw, the executive chairperson of biotechnology major Biocon, on Tuesday.

Addressing the sixth annual Global Technology Summit co-hosted with the Ministry of External Affairs, Mazumdar-Shaw said it was also very important to see the kind of inequities that existed in the world when it came to vaccines.

Also Read | Covavax: Serum Institute of India COVID-19 Vaccine for 3+ Kids by Mid-2022, Says Adar Poonawalla.

"Although we are now at a stage of vaccine adequacy during the time of vaccine inadequacy, there was a huge amount of inequity as we all know.... low middle income countries and middle income countries are still woefully short of having any safe level of immunisation," she said.

She said the COVID-19 pandemic brought out the importance of investing in affordable technologies, innovation to deliver important life-saving vaccines.

Also Read | Rajasthan Shocker: Woman Kills Father-In-Law After Brawl Over Domestic Dispute In Bundi District.

Talking about applicability of booster doses in view of the Omicron variant, Mazumdar-Shaw said if there's evidence to show that one can get more protection against severe disease with a booster shot, then nobody can argue against it.

"But at the same time, I think we also know that there's enough immune escape taking place with the new variants. So you know, would you like to start randomly immunizing everybody with a booster shot or should you basically target those who are vulnerable, those who are immunocompromised, those who are frontline workers with this kind of extra protection," she said.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)